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or the impact of prognostic factors is based on the time elapsed form 
the date of disease diagnosis or the beginning of treatment and the 
occurrence of different events related to the disease progression.
A first analysis on event free survival is often based on the 
comprehensive end-point in which all possible events are considered. 
Then subsample of events are also considered as end-points aiming to 
a deeper investigation of the treatment effect. An example in cancer 
studies is relapse free survival where the interest is the estimation 
of the probability to be free of tumour recurrence during follow-up. 
Looking to breast cancer, tumour recurrence is a composite end-point 
in which the occurrence of local relapses, contralateral tumours and 
distant or local metastases are frequently considered. The occurrence 
of death not related to the disease or secondary tumours different 
from breast cancer (defined as absorbing events) may be observed 
for some patients before tumour relapse and prevent the observation 
of the main end-point. On the contrary the occurrence of relapses 
does not prevent the observation of absorbing events. This situation 
is usually referred to as “semi-competing risks” [1]. In the absence 
of independent censoring, times to absorbing events are always 
observable and the incomplete observation relies only to relapse.
Relapse free survival is commonly estimated by Kaplan-Meier 
method considering time to occurrence events which are not 
included into the end-point as censored. It is an estimate of the 
marginal (net) survival function, i.e. the survival free from relapses in 
an hypothetical situation where the events of interest can be observed 
for all patients. In such a context, the use of Kaplan-Meier method 
is correct only in the case of independence among times to tumour 
recurrences and times to competing events, otherwise the knowledge 
of the multivariate distribution of time to events is needed.
It can be assumed that if no absorbing events occurred before 
relapse, time to relapse and the time to absorbing events would be 
observed for all patients giving the complete “bivariate” distribution 
whose relevant characteristic is the structure of the association 
between time to relapse and time to absorbing events.
Abstract
In most clinical studies, the evaluation of the effect of a therapy and 
the impact of prognostic factors is based on relapse-free survival. 
Relapse free is a net survival, since it is interpreted as the relapse-
free probability that would be observed if all patients experienced 
relapse sooner or later. Death without evidence of relapse prevents 
the subsequent observation of relapse, acting in a semi-competing 
risks framework. Relapse free survival is often estimated by 
standard regression models after censoring times to death. The 
association between relapse and death is thus accounted for. 
However, to better estimate relapse free survival, a bivariate 
distribution of times to events needs to be considered, for example 
by means of copula models. We concentrate here on the copula 
graphic estimator, for which a pertinent regression model has 
been developed. No direct parametric estimation of the regression 
coefficient for the covariates is available and the evaluation of the 
impact of covariates on relapse free survival is based on graphical 
representation for each covariate singularly. The advantage of this 
approach is based on the relationship between net survival, and 
crude cumulative incidences. Regression models can be fitted for 
the latter quantities and the estimates can be used to compute 
net survival through a copula structure. Our proposal is based 
on flexible regression transformation model on crude cumulative 
incidences based on pseudo-values. An overall view of the joint 
association among covariates and relapse free survival is obtained 
through Multiple Correspondence Analysis. Moreover cluster 
analysis on MCA coordinates was used to synthesize covariate 
patterns and to estimates the corresponding relapse free survival 
curve. This approach has been applied to a large “historical” case 
series of patients with breast cancer.
Keywords
Relapse free survival, Semi-competing risks, Copula, Multivariate 
analysis, Breast cancer
Introduction
In most clinical studies, the evaluation of the effect of a therapy 
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As in semi-competing risks settings time to relapse can be only 
partially observable, a proposed solution is based on the assumption 
of a particular structure of the bivariate distribution. To avoid too 
rigid assumptions flexible structures may be preferred and this is the 
reason for which Copulas are arising a growing interest. Copulas are 
functions that join bivariate distribution functions to their univariate 
marginal uniform distribution functions [2,3], in this case the 
distribution of time to relapse and the distribution of time to absorbing 
events. An advantage of copulas is that the marginal distributions do 
not need to be defined, thus they can be parametric or non parametric 
as well. As Copulas are not directly estimable from semi-competing 
risks data, the proposed solution is to recur to their relationship with 
estimable functions i.e., crude cumulative incidences of relapse and 
absorbing events. Generally, crude cumulative incidence of a specific 
event is the probability of observing such an event as the first [4].
Several copula functions can be used to estimate net survival in 
clinical applications [2], but Archimedean Copulas are convenient 
because of the availability of a simple closed form estimator based 
on the relationship between copulas, overall survival and crude 
cumulative incidences [5]. A key parameter of copula functions is 
related to the association among times to different events. In the case 
of semi-competing risks setting some association estimators can be 
applied [1,6,7] and in the case of Clayton Copula a strong consistent 
estimator has been proposed [1].
In the presence of competing risks a regression model based on 
Copula graphical estimator has been proposed by Lo and Wilke [5]. 
The advantage of the proposal is the possibility to use regression 
models on cause specific hazards, sub distribution hazards, crude 
cumulative incidences (parametric or semi-parametric) and to 
combined results given a copula structure to evaluate the covariate 
effects on net survival.
Lo and Wilke showed the use of both parametric and semi-
parametric modes based on crude cumulative incidences and 
referred the possibility of the indirect estimation of crude cumulative 
incidences through cause specific hazards. In their method the 
evaluation of covariates impact on net survival is not based on the 
estimation of regression coefficients but on a graphical representation 
of the estimated marginal survival as a function of each single 
covariate levels (fixing the remaining covariates to their mean values).
In our approach, we adopted regression models on crude 
cumulative incidences pseudo values [8] including regression splines 
for estimating the shape of baseline, avoiding rigid assumptions on the 
shape of crude cumulative incidence curves and allowing flexibility. A 
log link was used to obtain a simple interpretation of model results in 
terms of relative risks [9]. Concerning the graphical representation, 
we first adopted a multivariate technique (multiple correspondence 
analysis) to represent the joint relationship among covariates in a 
plane (factorial plane). Then we projected the estimated marginal 
relapse free probabilities on the factorial plane, having the advantage 
of visualizing the relationship among relapse free survival and the 
whole set of covariates. Moreover, to summarize the multivariate 
structure, cluster analysis is performed in such a way to represents the 
estimated net survival probability curves as a function of identified 
patient’s profiles.
To show the procedure we used a large dataset of breast cancer 
with available long and accurate follow-up and information on main 
clinical and pathological characteristics.
Methods
Latent failure times and relationship among time functions
At the beginning of follow-up each patient is considered at risk 
for relapse and absorbing events, each one occurring to “latent” or 
“potential” failure times ( ),R AY Y .
The joint “survival” function i.e. the probability of relapsing after 
time Ry  and having an absorbing event after Ay  is:
( ) ( ), ,R R A A R AP Y y Y y S y y> > =
The survival probability at time t for relapse and absorbing events 
(overall survival) is:
( ) ( ) ( ), ,R AS t S t t P Y t Y t= = > >
It can be shown that the marginal distribution of YR from S(t) is a 
proper survival distribution in the hypothetical condition where the 
absorbing event before relapse has been removed:
( ) ( ) ( ),0 , 0R R AS t S t P Y t Y= = > >
This is the net survival function for relapse [4]. It is worth noting 
that in the case of independence the overall survival equals the 
product of net survivals for relapse and absorbing events.
The marginal distribution of AY  is always observable and is 
expressed as ( ) ( ) ( )0, 0,A R AS t S t P Y Y t= = > > .
The crude cumulative incidence of relapse, i. e. the probability that 
relapse is observe as first event, is: ( ) ( )( )min , ;R R D R RF t P Y Y Y Y t= = ≤
. In analogy the crude cumulative incidence of absorbing events is 
( ) ( )( )min , ;A R A A AF t P Y Y Y Y t= = ≤ .
The relationship between overall survival and crude cumulative 
incidences of relapse and absorbing events is:
( ) ( ) ( )( ) ( )1 ................ 1R AS t F t F t= − +
It is worth of note that overall survival and crude cumulative 
incidences are estimable also when ( )min ,R AY Y  and ( )( )arg min ,R AY Y  
are only known.
Copulas
Concerning time to relapse and time to absorbing events, the 
general representation of Archimedean Clayton Copula [10] is:
( ) ( ) ( )
1
1 1 1, 1R A R R A AS y y S y S y
θ θ θ− − − = − − 
, where θ > 0
Given an Archimedean copula, marginal survival can be estimated 
by crude cumulative incidences [11].
Considering the discrete time nature of the observed data, an 
empirical estimator can be written as follows:
( ) ( )
1
1RS t k θθ
−= + , where ( )
( )
( ) ( )
1
0
................ 2t Ruk S u f u
θ− +
=
= −∑
where ( ) ( ) ( )1R R Rf u F u F u= − −  can be estimated by the method 
for competing risks [12] and ( )S u  can be estimated by Kaplan-Meier 
Method on “overall event”, or by crude cumulative incidences as 
reported in (1).
In the presence of covariates the approach has been generalized by 
Lo and Wilke by modelling crude cumulative incidences in function 
of covariates and plugging the estimates in (2).
From a practical perspective, in the case of a covariate xp. 
measured on qualitative or ordinal scale it is possible to trace ( )RS t  
for different values of xp and in the case of a covariate measured on a 
continuous scale a “binning” approach could be used.
The association between non terminal and terminal event
With semi-competing risks data, the dependence between time to 
relapse and time to absorbing events provides information about the 
extent to which the occurrence of a relapse hastens the occurrence of 
absorbing events. Specific approaches for estimating this association 
have been proposed in the literature and have to be adopted in a 
semi-competing risks analysis, by specifying the form of the bivariate 
distribution of times to events [1,6,7].
Given a time to relapse Ry  and a time to absorbing events Ay , the 
parameter θ can be interpreted as the ratio between the instantaneous risk 
of absorbing events at time Ay , given absorbing events has not occurred 
till Ay  and relapse has occurred at time Ry , and the instantaneous risk 
of absorbing events at time Ay , given absorbing events has not occurred 
till Ay  and relapse has not occurred till Ry . The ratio between the two 
above mentioned instantaneous risks is supposed to be constant in time. 
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A positive value of θ indicates that the occurrence of relapse increases the 
risk of absorbing events. A null value of θ indicates that time to relapse 
and time to absorbing events are independent
Modelling crude cumulative incidences by pseudo-values
Crude cumulative incidences can be modelled by transformation 
models: ( )( ) ( )kg F t t xα β= + .
Where g is the link function, ( )tα  is the “baseline” and xβ  is the 
linear predictor for covariates effect.
Models estimates can be obtained recurring to pseudo-values of 
crude cumulative incidences [8]. Firstly J time points are chosen from 
follow-up times: 1 ... ...j Jτ τ τ< < < . Then, for the event k (k = 1,2) and 
for the time jτ  the pseudo value for each subject s (s = 1,...,n) is defined 
as follows:
( ) ( ) ( )1 sksj k j k jnF n Fθ τ τ−= − −
 
, where ( )k jF τ

 is the non 
parametric estimate of crude cumulative incidence at jτ on the whole 
sample and ( )sk jF τ−
  is the corresponding estimate obtained after 
deleting the subject s from the sample. ( )tα  can be modelled by a 
vector y of J-1 dummy variables or, to obtain a smoothed shape, by 
regression splines [13].
For each subject J pseudo-values are calculated, thus for a sample 
of n subjects a matrix of n J⋅  rows is considered for the regression 
model. Taking into account the correlation among pseudo-values 
of the same subject, generalized estimating equations (GEE) can be 
used. Different structures for the correlation are available in standard 
software which can be considered, nevertheless no substantial 
influence of the structure on the final model estimates have been 
shown [8].
Different link functions allow to obtain clinically useful measures 
by a simple relationships with model regression coefficients (see [9] 
for details).
Because of the easily interpretation of relative risk, the log link 
was used for modelling crude cumulative incidences.
For the implementation R software was used: package “pseudo” 
for obtaining pseudo-values for crude cumulative incidences, package 
“geepack” (function geese) for model estimation with the following 
options: family Gaussian, link log, scale. fix = TRUE, scale. value = 
1, package “rms” (function rcspline. eval) for including splines bases 
into the model.
Evaluation of model fitting
As the marginal survival for relapse depends on the estimated 
crude cumulative incidences, model fitting evaluation for pseudo-
values models were performed for both relapse and absorbing events. 
A graphical approach was applied to compare observed and expected 
crude cumulative incidences. Firstly for each one of fixed times 
( )1 ... ...j Jτ τ τ< < <  used for calculating pseudo-values and for each 
subject s, the estimated crude cumulative incidence is obtained by 
gee model results on the basis of subject covariate vector ( ): ;s k j sX F xτ

. Then, for each time, the expected crude cumulative incidence is 
calculated as: ( ) ( )1
1 ,nek k k j ssF F Xn
τ τ
=
 =  ∑
  . The observed incidences 
are obtained by non parametric estimated crude cumulative 
incidences on the whole case series.
Visualization of the relationship among covariates and 
marginal survival
The approach proposed by Lo and Wilke allows to evaluate 
the relationship between marginal survival and each covariate by 
graphical representation of survival curves by fixing, as an example, 
the remaining covariates to their mean values.
This is useful for the effect of the single covariate but it does not 
allow to evaluate the covariate’s joint effect. To this aim the estimated 
marginal survival probabilities can be represented on a graph which 
summarizes the data structure: in the case of both continuous and 
categorical covariates multiple correspondence analysis (MCA) plot.
MCA is an exploratory multivariate technique which allows to 
visualize the association structure of a multidimensional contingency 
table. Variables and subjects can be plotted onto a subspace (usually a 
plane) defined by the factorial axes, which mainly contribute to explain 
the total variability of the original data, according to new coordinates 
(factorial scores). Considering the origin of factorial axes, the angular 
distance among categories and subjects is related to their mutual 
associations. Subjects which are projected close together shared 
similar covariates pattern (row-profiles) and modalities of covariate 
which are projected close together shared similar joint preferences 
of subjects (columns-profiles) [14]. As MCA is based on categorical 
covariates then covariates measured on the continuous scales should 
be firstly categorised. To visualize the association between estimated 
marginal survival probabilities and the pattern of association among 
variables, estimates survival probabilities are plotted on the plane as 
passive variables, i.e they do not contribute to the identification of 
factorial axes but the position of their projected values on the plane 
allows to describe their association with the covariates association 
pattern [15]. As an aid to identify the characteristics of joint 
variable patterns which shared similar estimated marginal survival 
probabilities, values of these latter have been projected on the 
MCA plane by using a gray scale. This is a simplified version of the 
procedure reported in [16].
Presence of putative clusters of subjects can be identified by 
the visual inspection of the MCA plane but, for a more objective 
procedure, a cluster analysis can be performed on the subjects 
factorial scores (package FactoMineR). Finally to summarize the joint 
effect of covariates on estimated marginal survival, survival curves 
can be plotted for each identified cluster.
Results
Case series
Data regarding 654 women with small, non-metastatic primary 
breast cancer and submitted to surgery at the National Cancer Institute 
in Milan between 1985 and 1989 were analysed. All women received 
quadrantectomy, axillary dissection and radiotherapy (QUART), 
moreover axillary node positive women received adjuvant medical 
therapy: premenopausal and postmenopausal patients negative for 
estrogens receptors received chemotherapy, while postmenopausal 
patients positive for estrogens receptors received tamoxifen. All 
details of trials can be found in [17,18].
Endpoint of interest
Attention is focused here on time to relapse, such as intra breast 
tumour recurrence, omolateral or contralateral breast carcinoma 
and regional or distant metastases, because its distribution gives 
information on the progression of the disease and it is of concern in 
order to choice the best treatment strategy. The aim of the analysis is 
to evaluate the effect of covariates (axillary lymph nodes metastases, 
pathological tumour dimension, estrogens and progesterone receptor 
status and age) on relapse free survival.
In the case series the occurrence of primary tumours different 
from breast cancers during follow-up are considered as “absorbing 
events” because after their occurrence information on breast cancer 
relapse are no longer reported.
A related purpose is the evaluation of association between 
times to breast cancer relapse and times to “absorbing events”. This 
quantity, although of potential clinical interest, is not evaluated in 
original articles.
Results
The association parameter between breast cancer relapse and 
absorbing events estimated by means of Fine’s method is 7.18. This 
means that the association between the two events is quite high: 
people who experience a breast cancer relapse have an instantaneous 
risk of absorbing events about 7 times bigger than people who do not 
experience a relapse.
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In order to estimate net relapse free survival by means of copula 
graphic estimator, crude cumulative incidences for relapse and for 
absorbing events have to be computed for each subject. 576 patients 
have complete information on the above mentioned clinical variables. 
For this purpose we fit a pseudo-values regression model on relapse 
crude cumulative incidence and a pseudo-values regression model 
on absorbing events crude cumulative incidence. For both events 
generalized estimation equations model with link log was used. 
Baseline for relapse crude cumulative incidence was modelled by a 
restricted cubic spline with 4 knots and baseline for absorbing events 
crude cumulative incidence was modelled by a restricted cubic spline 
with 3 knots. Knots positions were defined by quantiles of event 
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Figure 1: Goodness of fit of crude cumulative incidence estimation.
Table 1: Relapse crude cumulative incidence regression model based on pseudo-
values. For each covariate the exponent of regression coefficient is estimate of 
the ratio between crude cumulative incidences. N0 and N1 indicates absence 
or presence of axillary lymph node metastases respectively. T is pathological 
tumour size (in cm). PgR +,- indicates > 25 or <= 25 femtomoles progesterone 
receptors per milligram of cytosolic protein respectively, ER +,- indicates > 10 
fmoli or <= 10 of estrogen receptors femtomoles per milligram of cytosolic protein 
respectively and Time, time’ and time’’ represents spline basis for time.
Estimate Standard Error Wald statistic p-value
(Intercept) -5.074 0.387 172.11 < 0.001
time 0.07 0.008 81.643 < 0.001
time' -0.284 0.041 47.427 < 0.001
time'' 0.48 0.074 42.294 < 0.001
PGR (+ vs. -) 0.083 0.142 0.339 0.561
ER (+ vs. -) 0.313 0.172 3.317 0.069
T (1-2 vs ≤ 1) 0.628 0.187 11.323 0.001
T (> 2 vs. ≤ 1) 0.888 0.203 19.207 < 0.001
N (1 vs. 0) 0.163 0.112 2.117 0.146
age (41-50 vs. ≤ 40) -0.245 0.162 2.272 0.132
age (51-60 vs. ≤ 40) -0.229 0.168 1.861 0.172
age (> 60 vs. ≤ 40) -0.63 0.21 9.044 0.003
Table 2: Absorbing events crude cumulative incidence regression model based 
on pseudo-values. For each covariate the exponent of regression coefficient 
is the estimate of the ratio between crude cumulative incidences. N0 and N1 
indicates absence or presence of axillary lymph node metastases respectively. T 
is pathological tumour size (in cm). PgR +,- indicates > 25 or <= 25 femtomoles 
progesterone receptors per milligram of cytosolic protein respectively, ER +,- 
indicates >10 fmoli or <= 10 of estrogen receptors femtomoles per milligram of 
cytosolic protein respectively time and time’ are the spline bases for time.
Estimate Standard Error Wald statistic p-value
(Intercept) -4.954 0.666 55.281 < 0.001
time 0.02 0.004 26.545 < 0.001
time' -0.009 0.005 3.023 0.082
PGR (+ vs. -) -0.366 0.337 1.181 0.277
ER (+ vs. -) -0.488 0.408 1.426 0.232
T (1-2 vs. ≤ 1) -0.274 0.393 0.489 0.484
T (> 2 vs. ≤ 1) -0.469 0.55 0.725 0.394
N (1 vs. 0) -0.139 0.36 0.149 0.699
age (51-60 vs. ≤50) 0.658 0.427 2.373 0.123
age (> 60 vs. ≤ 50) 1.576 0.427 13.597 < 0.001
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Figure 2: MCA plot of the pattern of the covariates together with the relapse 
free survival for each subject at (A) 5 years; (B) 10 years; and (C) 15 years.
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MCA plane (as bubbles), to describe the association with the pattern 
of clinical-pathological characteristics. The dimension of the bubbles 
are proportional to frequencies of subjects for each combination of 
covariates and the gray intensities of the bubble are proportional to 
relapse-free survival (Figure 2). It can be noted that higher risk of 
relapse is mainly associated with young age, lymph node metastases 
and pathological tumour size > 2 cm and that after 10 years of follow-
up women can still experience relapse, in fact relapse free survival 
decreases from 5 years to 10 years and to 15 years.
To synthesize the results of MCA and identify potential profiles 
of subjects sharing similar characteristics a cluster analysis is applied 
to the subject coordinates for first two factorial axes. Three clusters 
are identified. The distributions of patients characteristics within 
clusters are represented in figure 3. In order to better understand 
the relative contribution of each variable in clusters identification, a 
classification tree (package tree in R software) was used (Figure 4). 
The main characteristics of subjects in cluster 1 are: axillary lymph 
nodes metastases, positive estrogens receptors and tumour dimension 
more than 1 (117 women on 194 classified in cluster 1). The main 
characteristics of subjects in cluster 2 are: no axillary lymph nodes 
metastases, positive estrogens receptors and tumour dimension less 
than 2 and age more than 40 (234 women on 270 classified in cluster 
2). The main characteristics of subjects in cluster 3 are: no axillary 
lymph nodes metastases, negative estrogens and progesterone 
receptors (70 women on 112 classified in cluster 3).
In order to summarize the prognostic results, the copula 
graphical estimated relapse free survival curves for each cluster are 
plotted in figure 5. The greater divergence is observed between cluster 
1 and the other two clusters. On the contrary relapse free survival 
curves of clusters 2 and 3 are very similar. The main characteristics 
than distinguish cluster 1 and clusters 2-3 are axillary lymph nodes 
metastases (positive in cluster 1 and negative in clusters 2-3) and 
tumour dimension (bigger in cluster 1). The main characteristics than 
distinguish clusters 1-2 and cluster 3 are hormones receptor status 
(positive in clusters 1-2 and negative in cluster 3).
Discussion
times in the original dataset. The remaining covariates were included 
by dummy variables. Time dependent effects of covariates were 
investigated by including interaction terms between covariates and 
basis of spline functions for time baseline. No time dependent effects 
were found statistically significant, thus an additive model with fixed 
effects of covariates was considered. Model results were reported in 
table 1 and table 2. It is worth of note that when modelling absorbing 
events the first two age class were joined as no events occurred in 
women less than 40 years, causing a non convergence of the model.
To evaluate the goodness of fit a calibration plot is drawn (Figure 
1), where the mean of the crude cumulative incidences curves 
estimated for each subject by pseudo-values regression model are 
compared with the crude cumulative incidences obtained by non-
parametric method of Kalbfleish and Prentice [12]. The results are 
very similar, proving that crude cumulative incidences are good 
estimated by the pseudo-values regression models.
The crude cumulative incidences estimated for each subject 
can be used to compute net relapse free survival, using a Clayton 
Archimedean copula, as given in formula (2).
To describe the association among clinical-pathological 
characteristics, a multiple correspondence analysis (MCA) is fitted. 
All covariates are used as active variables to obtain the plan of the 
first two factorial axes. Figure 2 summarize MCA results. The first 
factorial axis mainly contrasts women with positive and negative 
hormones receptors status. The second axis mainly contrasts women 
with no axillary lymph nodes metastases, small tumour and old age 
and women with axillary lymph nodes metastases, bigger tumour and 
young age. Women with negative estrogens receptors tend to have also 
negative progesterone receptors (upper right quadrant), women with 
age 50-60 years have frequently no axillary lymph nodes metastases 
and tumours less than 1 cm (lower right quadrant), youngest women 
tend to have biggest tumours with axillary lymph nodes metastases 
(upper quadrants), finally women aged between 41-50 or more than 
60 tend to have positive hormones receptors and tumours of 1-2 cm 
(left quadrants).
The net relapse free survival probability estimated for each 
subject at 5, 10 and 15 years are plotted as passive variables on the 
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Figure 3: Distributions of patients characteristics within clusters.
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Figure 4: Classification tree for the joint contribution of the variables in clusters.
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Figure 5: Relapse free survival curves for the three clusters.
To evaluate treatment or covariate effects on specific events, 
common regression models are based on cause specific hazards 
(e.g., Cox regression model) or on sub distribution hazard (e.g., Fine 
regression model). It can be noted that the effect of a covariate on the 
hazard function cannot be directly translated into the corresponding 
effect on the survival function (e.g. proportional hazards does 
not imply proportional survival probabilities) thus results do not 
necessarily provide useful measures of direct clinical impact as for 
example relative risk or odds ratio. Proposal based on Pseudo values 
transformational models allow to directly estimates the covariate 
effect on clinically useful measures [9]. However when the interest 
is to evaluate the covariate effect on marginal (net) survival as in the 
case of relapse free survival, “classical” regression model or the above 
mentioned transformation models for survival data do not provide 
direct information and specific approaches are needed. Because of the 
availability of partial information on multivariate time distribution 
some structural assumptions must be made accounting for clinical 
considerations which suggest the more suitable copula. Only in 
presence of independence among events the analysis on each event 
can simply performed by considering censored the times to other 
events.
Regression models on marginal hazard based on Archimedean 
copulas are available in the case of semi competing risks [19]. 
Dedicated software is needed and, till now, routines or functions or 
procedures which can be used in the widely diffuse statistical software 
are not available. The above mentioned papers reports in detail 
likelihood functions and provides some suggestions for programming 
but this is not a simple task. Moreover, these models are based on net 
hazard thus regression coefficients do not provide directly “clinically 
useful measures” on covariate impact on net survival.
The proposal of Lo and Wilke is an useful step to overcome the 
problem of difficult model implementation, although a quantification 
of the covariates effect of net survival cannot be obtained as happen 
in regression model coefficients. A limitation of their approach is the 
possibility to shows only the effect of each covariate one by one.
To our knowledge, an application allowing to evaluate the 
covariates joint effect has not been previously presented. We extended 
their approach to visualize the joint role of covariates on marginal 
survival. This is preferred since clinical covariates are often correlated. 
The advantages of our approach is the possibility to use standard 
software for all steps consisting in: a flexible estimate of marginal 
survival obtained by combining pseudo values model results (using 
formulas reported in [5]) and a multivariate technique to show joint 
covariate impact. MCA and cluster analysis may suggest risk groups 
which can be further analysed and confirmed by validation.
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